Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

EMEIS Aktie

 >EMEIS Aktienkurs 
11.68 EUR    -0.3%    (Tradegate)
Ask: 11.82 EUR / 60 Stück
Bid: 11.66 EUR / 60 Stück
Tagesumsatz: 665 Stück
Realtime Kurs von 8 bis 22 Uhr!
EMEIS Aktie über LYNX handeln
>EMEIS Performance
1 Woche: +9,7%
1 Monat: +16,5%
3 Monate: +16,1%
6 Monate: +94,3%
1 Jahr: -10,2%
laufendes Jahr: +100,0%
>EMEIS Aktie
Name:  EMEIS ACT.NOM. EO 0,01
Land:  Frankreich
Sektor:  Gesundheit
ISIN/ Wkn:  FR001400NLM4 / A403M5
Symbol/ Ticker:  OPA1 (Frankfurt)
Kürzel:  FRA:OPA1, ETR:OPA1, OPA1:GR
Index:  -
Webseite:  https://www.emeis-group.c..
Marktkapitalisierung:  1820 Mio. EUR
Umsatz:  5640 Mio. EUR
EBITDA:  81.14 Mio. EUR
Gewinn je Aktie:  -2.62 EUR
Schulden:  8860 Mio. EUR
Liquide Mittel:  518.83 Mio. EUR
Umsatz-/ Gewinnwachstum:  7.7% / -
KGV/ KGV lG:  0.1 / -
KUV/ KBV/ PEG:  0.32 / 1.05 / -
Gewinnm./ Eigenkapitalr.:  -7.31% / -23.01%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Div. Historie:  09.07.21 - 900€
12.07.19 - 1.2€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EMEIS, ORPEA
Letzte Datenerhebung:  06.07.25
>EMEIS Eigentümer
Aktien: 161.23 Mio. St.
f.h. Aktien: 95.37 Mio. St.
Insider Eigner: -
Instit. Eigner: 55.68%
>EMEIS Peer Group

 
26.06.25 - 18:39
emeis 2025 Annual General Meeting (Business Wire)
 
Summary of Voting ResultsPUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Guillaume Pepy, Chairman of the Board of Directors: "Today, we are particularly proud to announce, together with the Board of Directors and the Executive Management, that following the vote at our Annual General Meeting, emeis has become a mission-driven company. We have enshrined four major mission commitments in our statutes: The first: “Striving to change the way one looks at the most vulnerable and those close to them, to ensure they are truly included”, because bonding with others is also a part of care. The second: "Contributing to the fair recognition and attractiveness of our care professions", because they have never been so vital. The third: "Making care for the most vulnerable a major contribution to local social cohesion", because it is essential to stand by all those who are committed. The fourth: "Innovating to foster a planet-friendly care that respects living t...
12.05.25 - 11:45
Emeis Q1 sales up 6.2% as occupancy rises, nursing homes lead growth (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.05.25 - 07:33
emeis: Sales and business to end-March 20251 (Business Wire)
 
Further rise in occupancy rates in France and abroad Occupancy rates growth, particularly in nursing homes (France, Northern Europe, Central Europe) Organic sales growth of +6.2%2, Occupancy rate up +2pts PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Occupancy rate: further improvement in the first quarter, +2 points on average Continued improvement in the Group's average occupancy rate, up +2pts to 87.0% (vs. 85.0% in Q1 2024 and 83.0% in Q1 2023), and reaching 88.0% on the mature scope (excluding recently opened facilities). Occupancy rate for nursing homes up +2.1pts to 86.4% (vs. 84.3% in Q1 2024 and 81.8% in Q1 2023) Strong increases in Northern Europe (+3pts to 85.3%), Central Europe (+2.6pts to 91.6%) and in France (+1.7pt to 86.4%) First-quarter organic sales growth of +6.2%, driven by nursing homes and international markets Organic sales growth of +6.2%, reflecting the gradual turnaround in the Group's activities following the measures taken over the past 24 months, d...
16.04.25 - 22:15
emeis: 2024 Full-Year Results (Business Wire)
 
Trajectory for recovery confirmed Improvement in CSR fundamentals 2024 guidance beaten, with an operational recovery in the second half 2025 EBITDAR expected to rise between +15% and +18%, on a like-for-like basis PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Improvement in CSR fundamentals: a lever for growth in occupancy rates and revenue Improved quality indicators: resident satisfaction rate of 93%, +3 points above the 2022, and Net Promoter Score up +14 points over the same period. 125 facilities audited by the French National Health Authority (HAS) in 2024, with an average score of 3.89/4 Solid organic revenue growth (+8.3%), particularly in nursing homes (+10.8%) Occupancy rates up in all areas and all core activities (by +2.7 points on average, to 85.8%), and an encouraging start to 2025 with an average occupancy rate in January and February up almost +2 points compared to the start of 2024 Upturn in operational performance during the year: operational recovery under way ...
06.02.25 - 07:36
emeis: 2024 Guidance Beaten (Business Wire)
 
2024 business activity and revenue1 Trajectory for recovery confirmed Solid operational recovery seen in the second half of 2024 2025 EBITDAR expected to rise between +15% and +18%, on like-for-like basis €916m in disposals already completed or securedPUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Improvement in fundamental indicators Resident satisfaction rate of 93%, almost +3 points above the 2022 level Net Promoter Score from residents up +13 points over the same period Rate of conversion of visits into resident admissions of over 60% in the second half of 2024 and number of admissions to our facilities up by +10% in 2024 in France Stability of care teams: staff turnover and absenteeism rates are down, reinforcing continuity and quality of care Strong business growth Solid organic revenue growth (+8.3%), particularly in nursing homes (+10.8%), reflecting the benefits of measures taken since mid-2022 Occupancy rates up in all areas and all core activities (by 2.7 points on av...
22.09.24 - 21:49
XFRA : CAPITAL ADJUSTMENT INFORMATION - 24.09.2024 - FR001400NLM4 (XETRA)
 
Das Instrument OPA1 FR001400NLM4 EMEIS ACT.NOM. EO 10,- EQUITY wird cum Kapitalmassnahme gehandelt am 23.09.2024 und ex Kapitalmassnahme am 24.09.2024 The instrument OPA1 FR001400NLM4 EMEIS ACT.NOM. EO 10,- EQUITY is traded cum capital adjustment on 23.09.2024 and ex capital adjustment on 24.09.2024...
03.09.24 - 07:45
Orpea appoints Jean-Marc Boursier as CFO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.06.24 - 19:03
ORPEA: emeis 2024 Annual General Meeting, Summary of Voting Results (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
03.06.24 - 18:51
ORPEA: emeis Sells a Real-Estate Portfolio of Three Nursing Homes in Ireland Worth a Total Value of Around €56 Million (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!